BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 35939916)

  • 1. Inhibition of hypoxia-inducible factor 1 by acriflavine renders glioblastoma sensitive for photodynamic therapy.
    Ma S; Wang F; Dong J; Wang N; Tao S; Du J; Hu S
    J Photochem Photobiol B; 2022 Sep; 234():112537. PubMed ID: 35939916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of hypoxia inducible factor 1 and topoisomerase with acriflavine sensitizes perihilar cholangiocarcinomas to photodynamic therapy.
    Weijer R; Broekgaarden M; Krekorian M; Alles LK; van Wijk AC; Mackaaij C; Verheij J; van der Wal AC; van Gulik TM; Storm G; Heger M
    Oncotarget; 2016 Jan; 7(3):3341-56. PubMed ID: 26657503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia inducible factor (HIF-1a and HIF-2a) expression in early esophageal cancer and response to photodynamic therapy and radiotherapy.
    Koukourakis MI; Giatromanolaki A; Skarlatos J; Corti L; Blandamura S; Piazza M; Gatter KC; Harris AL
    Cancer Res; 2001 Mar; 61(5):1830-2. PubMed ID: 11280732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The HIF1α-PDGFD-PDGFRα axis controls glioblastoma growth at normoxia/mild-hypoxia and confers sensitivity to targeted therapy by echinomycin.
    Peng G; Wang Y; Ge P; Bailey C; Zhang P; Zhang D; Meng Z; Qi C; Chen Q; Chen J; Niu J; Zheng P; Liu Y; Liu Y
    J Exp Clin Cancer Res; 2021 Sep; 40(1):278. PubMed ID: 34470658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physiological oxygen concentration alters glioma cell malignancy and responsiveness to photodynamic therapy in vitro.
    Albert I; Hefti M; Luginbuehl V
    Neurol Res; 2014 Nov; 36(11):1001-10. PubMed ID: 24923209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mir-370-3p Impairs Glioblastoma Stem-Like Cell Malignancy Regulating a Complex Interplay between HMGA2/HIF1A and the Oncogenic Long Non-Coding RNA (lncRNA) NEAT1.
    Lulli V; Buccarelli M; Ilari R; Castellani G; De Dominicis C; Di Giamberardino A; D Alessandris QG; Giannetti S; Martini M; Stumpo V; Boe A; De Luca G; Biffoni M; Marziali G; Pallini R; Ricci-Vitiani L
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32443824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia-inducible miR-196a modulates glioblastoma cell proliferation and migration through complex regulation of NRAS.
    Takkar S; Sharma V; Ghosh S; Suri A; Sarkar C; Kulshreshtha R
    Cell Oncol (Dordr); 2021 Apr; 44(2):433-451. PubMed ID: 33469841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Q6, a novel hypoxia-targeted drug, regulates hypoxia-inducible factor signaling via an autophagy-dependent mechanism in hepatocellular carcinoma.
    Liu XW; Cai TY; Zhu H; Cao J; Su Y; Hu YZ; He QJ; Yang B
    Autophagy; 2014 Jan; 10(1):111-22. PubMed ID: 24220190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of hypoxia-inducible factor-1alpha overexpression by cobalt chloride enhances cellular resistance to photodynamic therapy.
    Ji Z; Yang G; Shahzidi S; Tkacz-Stachowska K; Suo Z; Nesland JM; Peng Q
    Cancer Lett; 2006 Dec; 244(2):182-9. PubMed ID: 16427735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of HIF1A From Pancreatic Cancer Cells Increases Expression of PPP1R1B and Degradation of p53 to Promote Invasion and Metastasis.
    Tiwari A; Tashiro K; Dixit A; Soni A; Vogel K; Hall B; Shafqat I; Slaughter J; Param N; Le A; Saunders E; Paithane U; Garcia G; Campos AR; Zettervall J; Carlson M; Starr TK; Marahrens Y; Deshpande AJ; Commisso C; Provenzano PP; Bagchi A
    Gastroenterology; 2020 Nov; 159(5):1882-1897.e5. PubMed ID: 32768595
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Shi Y; Jiang J; Cui Y; Chen Y; Dong T; An H; Liu P
    DNA Cell Biol; 2021 Jan; 40(1):93-100. PubMed ID: 33181035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dihydroartemisinin Increases the Sensitivity of Photodynamic Therapy Via NF-κB/HIF-1α/VEGF Pathway in Esophageal Cancer Cell in vitro and in vivo.
    Li Y; Sui H; Jiang C; Li S; Han Y; Huang P; Du X; Du J; Bai Y
    Cell Physiol Biochem; 2018; 48(5):2035-2045. PubMed ID: 30099443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergism of a novel MCL‑1 downregulator, acriflavine, with navitoclax (ABT‑263) in triple‑negative breast cancer, lung adenocarcinoma and glioblastoma multiforme.
    Lee A; Jin HO; Masudul Haque M; Kim HY; Jung H; Park JH; Kim I; Song JY; Yoon HK; Kim HK; Han J; Park IC; Kim KS; Park SG
    Int J Oncol; 2022 Jan; 60(1):. PubMed ID: 34913076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiangiogenic treatment enhances photodynamic therapy responsiveness in a mouse mammary carcinoma.
    Ferrario A; von Tiehl KF; Rucker N; Schwarz MA; Gill PS; Gomer CJ
    Cancer Res; 2000 Aug; 60(15):4066-9. PubMed ID: 10945611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-power photodynamic therapy induces survival signaling in perihilar cholangiocarcinoma cells.
    Weijer R; Broekgaarden M; van Golen RF; Bulle E; Nieuwenhuis E; Jongejan A; Moerland PD; van Kampen AH; van Gulik TM; Heger M
    BMC Cancer; 2015 Dec; 15():1014. PubMed ID: 26705830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photodynamic process induced by chloro-aluminum phthalocyanine nanoemulsion in glioblastoma.
    Castilho-Fernandes A; Lopes TG; Primo FL; Pinto MR; Tedesco AC
    Photodiagnosis Photodyn Ther; 2017 Sep; 19():221-228. PubMed ID: 28599959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photodynamic Therapy Combined with Antihypoxic Signaling and CpG Adjuvant as an In Situ Tumor Vaccine Based on Metal-Organic Framework Nanoparticles to Boost Cancer Immunotherapy.
    Cai Z; Xin F; Wei Z; Wu M; Lin X; Du X; Chen G; Zhang D; Zhang Z; Liu X; Yao C
    Adv Healthc Mater; 2020 Jan; 9(1):e1900996. PubMed ID: 31746153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIF1A Alleviates compression-induced apoptosis of nucleus pulposus derived stem cells via upregulating autophagy.
    He R; Wang Z; Cui M; Liu S; Wu W; Chen M; Wu Y; Qu Y; Lin H; Chen S; Wang B; Shao Z
    Autophagy; 2021 Nov; 17(11):3338-3360. PubMed ID: 33455530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric oxide antagonism to glioblastoma photodynamic therapy and mitigation thereof by BET bromodomain inhibitor JQ1.
    Fahey JM; Stancill JS; Smith BC; Girotti AW
    J Biol Chem; 2018 Apr; 293(14):5345-5359. PubMed ID: 29440272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dihydroartemisinin prompts amplification of photodynamic therapy-induced reactive oxygen species to exhaust Na/H exchanger 1-mediated glioma cells invasion and migration.
    Hou K; Liu J; Du J; Mi S; Ma S; Ba Y; Ji H; Li B; Hu S
    J Photochem Photobiol B; 2021 Jun; 219():112192. PubMed ID: 34000476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.